Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
4,098,087
-
Shares change
-
-131,172
-
Total reported value, excl. options
-
$13,112,972
-
Value change
-
-$296,661
-
Put/Call ratio
-
288%
-
Number of buys
-
13
-
Number of sells
-
11
-
Price
-
$3.20
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2018
As of 30 Jun 2018 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,098,087 shares of stock of the company.
Largest 10 holders included FMR LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Alethea Capital Management, LLC, Sio Capital Management, LLC, Opus Point Partners Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and JPMORGAN CHASE & CO.
This table shows 42 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.